These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. Ge HS, Huang XF, Zhang W, Zhao JZ, Lin JJ, Zhou W. Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398 [Abstract] [Full Text] [Related]
3. In vitro maturation for patients with polycystic ovary syndrome. Reinblatt SL, Buckett W. Semin Reprod Med; 2008 Jan; 26(1):121-6. PubMed ID: 18181090 [Abstract] [Full Text] [Related]
5. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer]. Yu R, Lin J, Zhao JZ, Wang PY, Xiao SQ, Zhang W. Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109 [Abstract] [Full Text] [Related]
20. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment. Chian RC, Buckett WM, Abdul Jalil AK, Son WY, Sylvestre C, Rao D, Tan SL. Fertil Steril; 2004 Dec; 82(6):1675-8. PubMed ID: 15589878 [Abstract] [Full Text] [Related] Page: [Next] [New Search]